The purpose of this study is to obtain an assessment of the efficacy and safety of renal denervation in the presence of three standard antihypertensive medications.
Study Type: Interventional (Clinical Trial)
Actual Enrollment: 106 participants
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Actual Study Start Date: July 2015
Estimated Primary Completion Date: January 2021
Estimated Study Completion Date: February 2021
- Experimental: Renal Denervation
- Sham Comparator: Sham Procedure
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
|Date last updated at source||2018-04-17|
|Study start date||2015-07-01|
|Estimated primary completion date||2021-01-01|